Order Article Reprints

Coppola A, Rivolta GF, Quintavalle G, Matichecchia A, Riccardi F, Rossi R, Benegiamo A, Ranalli P, Coluccio V, Tagliaferri A. Six-Year, Real-World Use of Prophylaxis with Recombinant Factor IX–Albumin Fusion Protein (rIX-FP) in Persons with Hemophilia B: A Single-Center Retrospective–Prospective Study. Journal of Clinical Medicine. 2024; 13(5):1518. https://doi.org/10.3390/jcm13051518

Coppola, Antonio, Gianna Franca Rivolta, Gabriele Quintavalle, Annalisa Matichecchia, Federica Riccardi, Rossana Rossi, Anna Benegiamo, Paola Ranalli, Valeria Coluccio, and Annarita Tagliaferri. 2024. "Six-Year, Real-World Use of Prophylaxis with Recombinant Factor IX–Albumin Fusion Protein (rIX-FP) in Persons with Hemophilia B: A Single-Center Retrospective–Prospective Study" Journal of Clinical Medicine 13, no. 5: 1518. https://doi.org/10.3390/jcm13051518

Coppola, A., Rivolta, G. F., Quintavalle, G., Matichecchia, A., Riccardi, F., Rossi, R., Benegiamo, A., Ranalli, P., Coluccio, V., & Tagliaferri, A. (2024). Six-Year, Real-World Use of Prophylaxis with Recombinant Factor IX–Albumin Fusion Protein (rIX-FP) in Persons with Hemophilia B: A Single-Center Retrospective–Prospective Study. Journal of Clinical Medicine, 13(5), 1518. https://doi.org/10.3390/jcm13051518